1

Stevanato

#2754

Rank

$5B

Marketcap

IT Italy

Country

Stevanato
Leadership team

Mr. Franco Stevanato (Exec. Chairman)

Mr. Franco Moro (CEO, COO & Director)

Mr. Marco Dal Lago (Chief Financial Officer)

Products/ Services
Health Care, Manufacturing, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Veneto, Veneto, Italy
Established
1949
Company Registration
SEC CIK number: 0001849853
Net Income
100M - 500M
Revenue
500M - 1B
Traded as
STVN
Overview
Location
Summary
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
History

Nuova Ompi, the first company of the Group, was founded in Venice in 1949 by Giovanni Stevanato, father of the actual president Sergio Stevanato. In 1959 the company moved to its current location: Piombino Dese, Padua – Italy.

A second company was established in 1971, specialized in the design and construction of high-speed precision machines and complete lines for the production and control of glass tube containers for pharmaceutical use.

In 1993 Stevanato Group purchased Alfamatic and with the acquisition of Medical Glass in 2005, the Group opened to the internationalization.

In 2007 the Group acquired Optrel , an Italian company specialized in the design and the construction of inspection machines for the pharmaceutical industry. In addition, Nuova Ompi launched the EZ-fill brand, starting with the production of sterile syringes.

In 2008 a new production plant called "Ompi of America" was built in Monterrey, Mexico.

Two years later the EZ-fill concept was extended to vials and cartridges.

In 2012 the Group doubled the Monterrey plant started the construction of a new plant in China .

In 2013 the Group acquired InnoScan, a Danish manufacturer of inspection machines for the pharmaceutical industry. In 2016 the Group acquired the Danish company SVM Automatik specialized in assembly, packaging and serialization solutions for the pharmaceutical industry and the operative units of Balda Group, specialized in high quality and high precision plastic solutions for diagnostic, pharmaceutical and medical device applications. In 2017 the third greenfield - Ompi do Brasil - plant was opened in Sete Lagoas.

Mission
Stevanato Group’s mission is to create an innovative and diversified portfolio of high quality primary packaging solutions that meet and exceed customer expectations.
Vision
Stevanato Group’s vision is to become the world leader in the primary packaging solutions market.
Key Team

Mr. Paolo Patri (Chief Technology Officer)

Ms. Lisa Miles (Sr. VP of Investor Relations)

Mr. Mauro Stocchi (Chief Bus. Officer)

Mr. Riccardo Butta (Pres of Americas)

Recognition and Awards
Stevanato Group has received numerous awards and recognitions, including the 2017 Frost & Sullivan Europe Company of the Year Award, the 2018 Red Dot Design Award, and the 2019 WorldStar Packaging Award.
References
Stevanato
Leadership team

Mr. Franco Stevanato (Exec. Chairman)

Mr. Franco Moro (CEO, COO & Director)

Mr. Marco Dal Lago (Chief Financial Officer)

Products/ Services
Health Care, Manufacturing, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Veneto, Veneto, Italy
Established
1949
Company Registration
SEC CIK number: 0001849853
Net Income
100M - 500M
Revenue
500M - 1B
Traded as
STVN